Bixiye
QP108-20 Commercial Pharmacy Benefit Update – New Drug-Related Step Therapy (ST) with Quantity Limit (QL) Criteria: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors and Combinations
Taariikhda uu dhaqangalayo Barnaamijka: Nov 11, 2020
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2271 - 2280 ee natiijooyinka 3167
Bixiye
P50R2-20 Update: eviCore is Changing Prior Authorization Guidelines used to Review Durable Medical Equipment and Post-Acute Care Services for Medicare Advantage Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020
Bixiye
P49R1-20 CERiS Review of High Dollar Claims
Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020
Bixiye
P78-20 Reminder: New Prior Authorization Timeframes Required by Legislation
Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020
Bixiye
P84-20 Predetermination Request Form for Commercial Lines of Business
Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020
Bixiye
P86-20 Appeals Policy for no Prior Authorization for Minnesota Health Care Programs
Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020
Bixiye
2020 November Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020
Bixiye
P81-20 eviCore Healthcare Specialty Utilization Management (UM) Program - Cardiology and Radiology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020
Bixiye
P85-20 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020
Bixiye
P80-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective January 4, 2021
Taariikhda uu dhaqangalayo Barnaamijka: Nov 02, 2020